Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 PCDHGB7 CD248 PCDHGB6 PCDHGB2 PCDHGA2 CAPN1 PCDH11Y PCDHB8 PCDHB6 PCDHB2 PCDHB18P PPP2R3A SULF2 CELSR3 VCAN LPL DCHS1 FER1L5 CDH4	1.47e-05	749	180	20	GO:0005509
GeneOntologyMolecularFunction	androstan-3-alpha,17-beta-diol dehydrogenase activity	AKR1C1 AKR1C2 HSD17B10	5.81e-05	9	180	3	GO:0047044
GeneOntologyMolecularFunction	retinal dehydrogenase activity	DHRS4L1 AKR1C1 AKR1C2	2.44e-04	14	180	3	GO:0001758
GeneOntologyMolecularFunction	androsterone dehydrogenase (B-specific) activity	AKR1C1 AKR1C2	4.79e-04	4	180	2	GO:0047042
GeneOntologyMolecularFunction	ketoreductase activity	AKR1C1 AKR1C2	4.79e-04	4	180	2	GO:0045703
GeneOntologyMolecularFunction	indanol dehydrogenase activity	AKR1C1 AKR1C2	4.79e-04	4	180	2	GO:0047718
GeneOntologyMolecularFunction	nuclear estrogen receptor activity	PDE3A ESR1	4.79e-04	4	180	2	GO:0030284
GeneOntologyMolecularFunction	chlordecone reductase activity	AKR1C1 AKR1C2	4.79e-04	4	180	2	GO:0047743
GeneOntologyMolecularFunction	estradiol 17-beta-dehydrogenase [NAD(P)+] activity	AKR1C1 AKR1C2 HSD17B10	7.34e-04	20	180	3	GO:0004303
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	PDE3A PDE6A CILP CDC14A NT5DC1 INPP4B LPIN1 NT5C1A PTPRN SYNJ2 PTPRR	7.84e-04	386	180	11	GO:0042578
GeneOntologyMolecularFunction	trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:0047115
GeneOntologyMolecularFunction	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:0047020
GeneOntologyMolecularFunction	17-beta-ketosteroid reductase (NADPH) activity	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:0072555
GeneOntologyMolecularFunction	17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:0047006
GeneOntologyMolecularFunction	lithocholic acid binding	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:1902121
GeneOntologyMolecularFunction	ketosteroid monooxygenase activity	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:0047086
GeneOntologyMolecularFunction	Delta4-3-oxosteroid 5beta-reductase activity	AKR1C1 AKR1C2	7.94e-04	5	180	2	GO:0047787
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	PDE3A PDE6A CILP SGSH CDC14A NT5DC1 INPP4B LPIN1 NT5C1A LIPE SULF2 PTPRN SYNJ2 PTPRR LPL HELZ2 PIWIL3	1.04e-03	807	180	17	GO:0016788
GeneOntologyMolecularFunction	geranylgeranyl reductase activity	AKR1C1 AKR1C2	1.18e-03	6	180	2	GO:0045550
GeneOntologyMolecularFunction	phosphatase activity	CILP CDC14A NT5DC1 INPP4B LPIN1 NT5C1A PTPRN SYNJ2 PTPRR	1.21e-03	287	180	9	GO:0016791
GeneOntologyMolecularFunction	nuclear steroid receptor activity	PDE3A ESR1 PGR	1.43e-03	25	180	3	GO:0003707
GeneOntologyMolecularFunction	17-beta-hydroxysteroid dehydrogenase (NADP+) activity	AKR1C1 AKR1C2	1.65e-03	7	180	2	GO:0072582
GeneOntologyMolecularFunction	alcohol dehydrogenase (NADP+) activity	DHRS4L1 AKR1C1 AKR1C2	1.80e-03	27	180	3	GO:0008106
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 PCDHB18P CELSR3 PTPRR PKD1 DCHS1 CDH4 PLXNB3	6.75e-12	187	177	16	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 PCDHB18P CELSR3 PTPRR PKD1 DCHS1 CLDN19 CDH4 PLXNB3	1.82e-09	313	177	17	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	EPHB6 ZNF703 DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 CAPN1 PCDH11Y CAMSAP3 PCDHB8 PCDHB6 AKNA PCDHB2 ITGA9 PCDHB18P CORO1A CELSR3 PTPRR PIK3CG PKD1 DCHS1 COL14A1 PLAUR CLDN19 BAIAP2 FUT7 CDH4 YTHDF2 PLXNB3	1.08e-08	1077	177	30	GO:0098609
GeneOntologyBiologicalProcess	cellular response to steroid hormone stimulus	VPS18 PDE3A ZNF366 ESR1 REST AKR1C1 AKR1C2 PGR NCOR2 KMT2D SCNN1B	7.24e-06	239	177	11	GO:0071383
GeneOntologyBiologicalProcess	anatomical structure regression	AMHR2 FLT1 CD248 SMAD9	2.28e-05	20	177	4	GO:0060033
GeneOntologyBiologicalProcess	retinal metabolic process	DHRS4L1 RBP4 AKR1C1 AKR1C2	2.80e-05	21	177	4	GO:0042574
GeneOntologyBiologicalProcess	C21-steroid hormone metabolic process	REST AKR1C1 AKR1C2 SCNN1B HSD17B10	4.07e-05	45	177	5	GO:0008207
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	VPS18 PDE3A ZNF366 ESR1 AKR1C1 AKR1C2 PGR NCOR2 KMT2D CYP26C1	5.11e-05	244	177	10	GO:0009755
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	VPS18 ZNF366 ESR1 AKR1C1 AKR1C2 PGR NCOR2 KMT2D CYP26C1	6.43e-05	202	177	9	GO:0141193
GeneOntologyBiologicalProcess	cellular response to organic cyclic compound	ZNF703 VPS18 PDE3A ZNF366 ESR1 REST AKR1C1 AKR1C2 PGR NCOR2 KMT2D RAPGEF3 PIK3CG SCNN1B SP5 SMAD9	6.93e-05	605	177	16	GO:0071407
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB8 PCDHB6 PCDHB2 DCHS1 CDH4	9.04e-05	53	177	5	GO:0016339
GeneOntologyBiologicalProcess	terpenoid catabolic process	AKR1C1 AKR1C2 CYP26C1	9.75e-05	11	177	3	GO:0016115
GeneOntologyBiologicalProcess	triglyceride metabolic process	ESR1 APOH GK5 LPIN1 LIPE PIK3CG LPL	1.14e-04	127	177	7	GO:0006641
GeneOntologyBiologicalProcess	retinoid metabolic process	DHRS4L1 RBP4 AKR1C1 AKR1C2 LIPE CYP26C1	1.18e-04	89	177	6	GO:0001523
GeneOntologyBiologicalProcess	triglyceride catabolic process	APOH LIPE PIK3CG LPL	1.21e-04	30	177	4	GO:0019433
GeneOntologyBiologicalProcess	diterpenoid metabolic process	DHRS4L1 RBP4 AKR1C1 AKR1C2 LIPE CYP26C1	1.60e-04	94	177	6	GO:0016101
GeneOntologyBiologicalProcess	aldehyde metabolic process	DHRS4L1 RBP4 REST AKR1C1 AKR1C2 SCNN1B	1.70e-04	95	177	6	GO:0006081
GeneOntologyBiologicalProcess	hormone metabolic process	ESR1 RBP4 REST AKR1C1 AKR1C2 TG LIPE CYP26C1 SCNN1B HSD17B10	1.89e-04	286	177	10	GO:0042445
GeneOntologyBiologicalProcess	isoprenoid catabolic process	AKR1C1 AKR1C2 CYP26C1	2.11e-04	14	177	3	GO:0008300
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	FLT1 VPS18 ZNF366 ESR1 PUM2 IRF7 AKR1C1 AKR1C2 PGR NCOR2 KMT2D CYP26C1	2.62e-04	416	177	12	GO:0030522
GeneOntologyBiologicalProcess	terpenoid metabolic process	DHRS4L1 RBP4 AKR1C1 AKR1C2 LIPE CYP26C1	2.93e-04	105	177	6	GO:0006721
GeneOntologyBiologicalProcess	primary alcohol metabolic process	RBP4 REST AKR1C1 AKR1C2 LIPE SCNN1B	3.08e-04	106	177	6	GO:0034308
GeneOntologyBiologicalProcess	negative regulation of hormone metabolic process	REST AKR1C1 AKR1C2	3.20e-04	16	177	3	GO:0032351
GeneOntologyBiologicalProcess	steroid hormone receptor signaling pathway	VPS18 PDE3A ZNF366 ESR1 PGR NCOR2 KMT2D	3.90e-04	155	177	7	GO:0043401
GeneOntologyBiologicalProcess	acylglycerol metabolic process	ESR1 APOH GK5 LPIN1 LIPE PIK3CG LPL	4.05e-04	156	177	7	GO:0006639
GeneOntologyBiologicalProcess	neutral lipid catabolic process	APOH LIPE PIK3CG LPL	4.14e-04	41	177	4	GO:0046461
GeneOntologyBiologicalProcess	acylglycerol catabolic process	APOH LIPE PIK3CG LPL	4.14e-04	41	177	4	GO:0046464
GeneOntologyBiologicalProcess	condensed mesenchymal cell proliferation	DCHS2 DCHS1	4.34e-04	4	177	2	GO:0072137
GeneOntologyBiologicalProcess	response to jasmonic acid	AKR1C1 AKR1C2	4.34e-04	4	177	2	GO:0009753
GeneOntologyBiologicalProcess	progesterone catabolic process	AKR1C1 AKR1C2	4.34e-04	4	177	2	GO:0006709
GeneOntologyBiologicalProcess	C21-steroid hormone catabolic process	AKR1C1 AKR1C2	4.34e-04	4	177	2	GO:0008208
GeneOntologyBiologicalProcess	cellular response to jasmonic acid stimulus	AKR1C1 AKR1C2	4.34e-04	4	177	2	GO:0071395
GeneOntologyBiologicalProcess	neutral lipid metabolic process	ESR1 APOH GK5 LPIN1 LIPE PIK3CG LPL	4.37e-04	158	177	7	GO:0006638
GeneOntologyBiologicalProcess	cellular response to fatty acid	AKR1C1 AKR1C2 KCNK4 LPL	4.55e-04	42	177	4	GO:0071398
GeneOntologyBiologicalProcess	response to steroid hormone	VPS18 PDE3A ZNF366 ESR1 REST AKR1C1 AKR1C2 PGR NCOR2 KMT2D SCNN1B	4.69e-04	381	177	11	GO:0048545
GeneOntologyBiologicalProcess	cellular response to hormone stimulus	VPS18 PDE3A ZNF366 ESR1 REST AKR1C1 AKR1C2 PGR LPIN1 NCOR2 KMT2D LPL CYP26C1 SCNN1B BAIAP2 FUT7	5.47e-04	727	177	16	GO:0032870
Domain	Cadherin_CS	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	4.47e-10	109	175	12	IPR020894
Domain	CADHERIN_1	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	6.82e-10	113	175	12	PS00232
Domain	Cadherin	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	6.82e-10	113	175	12	PF00028
Domain	CADHERIN_2	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	7.56e-10	114	175	12	PS50268
Domain	-	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	7.56e-10	114	175	12	2.60.40.60
Domain	CA	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	8.37e-10	115	175	12	SM00112
Domain	Cadherin-like	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	9.26e-10	116	175	12	IPR015919
Domain	Cadherin	DCHS2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 CELSR3 DCHS1 CDH4	1.13e-09	118	175	12	IPR002126
Domain	Cadherin_C	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2	1.15e-07	42	175	7	IPR032455
Domain	Cadherin_C_2	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2	1.15e-07	42	175	7	PF16492
Domain	Cadherin_2	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2	1.62e-07	65	175	8	PF08266
Domain	Cadherin_N	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2	1.62e-07	65	175	8	IPR013164
Domain	SUSHI	CD248 APOH HPR VCAN SEZ6	1.77e-04	56	175	5	PS50923
Domain	Sushi_SCR_CCP_dom	CD248 APOH HPR VCAN SEZ6	1.93e-04	57	175	5	IPR000436
Domain	Cadherin_tail	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2	3.86e-04	37	175	4	PF15974
Domain	Cadherin_CBD	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2	3.86e-04	37	175	4	IPR031904
Pubmed	Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element.	DUX4L9 DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	2.79e-16	12	186	8	10433963
Pubmed	Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy.	DUX4L9 DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	7.23e-16	13	186	8	17668377
Pubmed	The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	8.90e-16	8	186	7	17588759
Pubmed	DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	1.32e-14	10	186	7	17984056
Pubmed	Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	1.87e-13	13	186	7	7739628
Pubmed	Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	2.08e-12	17	186	7	11245978
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 PCDHB18P CELSR3	1.79e-11	80	186	10	10716726
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P CELSR3	1.88e-10	72	186	9	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 PCDHB18P	2.41e-10	74	186	9	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDH11Y PCDHB8 PCDHB6 PCDHB2 PCDHB18P	3.48e-10	77	186	9	10835267
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P	3.23e-09	68	186	8	11230163
Pubmed	BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization.	ESR1 PGR CHRD CHRDL1 SMAD9	3.69e-07	28	186	5	23103586
Pubmed	The homeobox transcription factor DUXBL controls exit from totipotency.	DUX4L9 DUX4L2 DUX4L4	6.00e-07	4	186	3	38509386
Pubmed	Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis.	AMHR2 REST PGR	6.00e-07	4	186	3	36282915
Pubmed	Expression profiling of immature thymocytes revealed a novel homeobox gene that regulates double-negative thymocyte development.	DUX4L9 DUX4L2 DUX4L4	6.00e-07	4	186	3	17911620
Pubmed	Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.	ESR1 PGR NCOR2	1.49e-06	5	186	3	20392877
Pubmed	CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.	ESR1 PGR NCOR2	1.49e-06	5	186	3	17347654
Pubmed	Characterization of genomic structures and expression profiles of three tandem repeats of a mouse double homeobox gene: Duxbl.	DUX4L9 DUX4L2 DUX4L4	1.49e-06	5	186	3	20063414
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB8 PCDHB6 PCDHB2 PCDHB18P	3.59e-06	20	186	4	11322959
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TPP2 ZNF703 ELP5 SCAMP1 CAMSAP3 KIAA1549 PFAS NBEA HID1 CDC14A NCOR2 PPP2R3A KMT2D PTPRN PTPRR RRP12 BAIAP2 ARHGEF2 ADGRL2	4.00e-06	1049	186	19	27880917
Pubmed	Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.	AKR1C1 AKR1C2 PGR	5.19e-06	7	186	3	19846565
Pubmed	MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor.	AKR1C1 AKR1C2 PGR	5.19e-06	7	186	3	22529366
Pubmed	The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection.	DUX4L9 DUX4L2 DUX4L4	5.19e-06	7	186	3	30765463
Pubmed	17Beta-HSD type 5 expression and the emergence of differentiated epithelial Type II cells in fetal lung: a novel role for androgen during the surge of surfactant.	SFTPC AKR1C1 AKR1C2	5.19e-06	7	186	3	16337335
Pubmed	I kappa B kinase alpha (IKKα) activity is required for functional maturation of dendritic cells and acquired immunity to infection.	MAP3K14 IRF7 BCL2L12	8.26e-06	8	186	3	23422957
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGB2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P	1.39e-05	57	186	5	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGB2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P	1.51e-05	58	186	5	30377227
Pubmed	Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages.	IRF7 BCL2L12 TNFRSF1A	2.41e-05	11	186	3	25049377
Pubmed	Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.	ESR1 PGR	2.84e-05	2	186	2	18631401
Pubmed	Molecular mechanism of estrogen receptor (ER)alpha-specific, estradiol-dependent expression of the progesterone receptor (PR) B-isoform.	ESR1 PGR	2.84e-05	2	186	2	15084345
Pubmed	In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.	ESR1 PGR	2.84e-05	2	186	2	24570392
Pubmed	Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.	MST1R PIK3CG	2.84e-05	2	186	2	19224914
Pubmed	Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells.	AKR1C1 AKR1C2	2.84e-05	2	186	2	8573067
Pubmed	Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis.	ESR1 PGR	2.84e-05	2	186	2	22004841
Pubmed	Lack of association of hormone receptor polymorphisms with migraine.	ESR1 PGR	2.84e-05	2	186	2	19175383
Pubmed	Heterogeneity of estrogen receptor α and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments.	ESR1 PGR	2.84e-05	2	186	2	29383962
Pubmed	Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast.	ESR1 PGR	2.84e-05	2	186	2	22580007
Pubmed	A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages.	CHRD CHRDL1	2.84e-05	2	186	2	11401399
Pubmed	Alu Deletions in LAMA2 and CDH4 Genes Are Key Components of Polygenic Predictors of Longevity.	LAMA2 CDH4	2.84e-05	2	186	2	36362280
Pubmed	Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.	ESR1 PGR	2.84e-05	2	186	2	26252518
Pubmed	Versican provides the provisional matrix for uterine spiral artery dilation and fetal growth.	PGR VCAN	2.84e-05	2	186	2	36423736
Pubmed	Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.	ESR1 PGR	2.84e-05	2	186	2	18391223
Pubmed	Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status.	ESR1 PGR	2.84e-05	2	186	2	22972951
Pubmed	Role of ERα in Mediating Female Uterine Transcriptional Responses to IGF1.	ESR1 PGR	2.84e-05	2	186	2	28586424
Pubmed	Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.	LYPD3 PLAUR	2.84e-05	2	186	2	17706320
Pubmed	Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis.	ESR1 PGR	2.84e-05	2	186	2	20959426
Pubmed	Versican V2 assembles the extracellular matrix surrounding the nodes of ranvier in the CNS.	VCAN UGT8	2.84e-05	2	186	2	19535585
Pubmed	Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging.	ESR1 PGR	2.84e-05	2	186	2	11897499
Pubmed	Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer.	ESR1 PGR	2.84e-05	2	186	2	26161666
Pubmed	Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.	ESR1 PGR	2.84e-05	2	186	2	12594000
Pubmed	Steroid receptor knockout models: phenotypes and responses illustrate interactions between receptor signaling pathways in vivo.	ESR1 PGR	2.84e-05	2	186	2	10582092
Pubmed	Differentiated expression of estrogen receptors (ER) and progesterone receptors (PgR) in ductal breast cancers.	ESR1 PGR	2.84e-05	2	186	2	19419938
Pubmed	Modeling single nucleotide polymorphisms in the human AKR1C1 and AKR1C2 genes: implications for functional and genotyping analyses.	AKR1C1 AKR1C2	2.84e-05	2	186	2	21217827
Pubmed	Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.	ESR1 PGR	2.84e-05	2	186	2	20844986
Pubmed	Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.	ESR1 PGR	2.84e-05	2	186	2	16537702
Pubmed	Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.	ESR1 PGR	2.84e-05	2	186	2	17885486
Pubmed	Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle.	LIPE LPL	2.84e-05	2	186	2	11809748
Pubmed	Neuralin-1 is a novel Chordin-related molecule expressed in the mouse neural plate.	CHRD CHRDL1	2.84e-05	2	186	2	11118896
Pubmed	Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient.	ESR1 PGR	2.84e-05	2	186	2	24114857
Pubmed	In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells.	ESR1 PGR	2.84e-05	2	186	2	16524927
Pubmed	OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications.	MAP3K14 OTUD7B	2.84e-05	2	186	2	27499151
Pubmed	A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer.	ESR1 PGR	2.84e-05	2	186	2	37199804
Pubmed	CDB-4124, a progesterone receptor modulator, inhibits mammary carcinogenesis by suppressing cell proliferation and inducing apoptosis.	ESR1 PGR	2.84e-05	2	186	2	21119048
Pubmed	Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice.	ESR1 MST1R	2.84e-05	2	186	2	22226043
Pubmed	C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis.	VCAN PLAUR	2.84e-05	2	186	2	30944246
Pubmed	Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status.	ESR1 PGR	2.84e-05	2	186	2	21736840
Pubmed	Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast.	ESR1 PGR	2.84e-05	2	186	2	19205874
Pubmed	Intraocular Metastases Secondary to Breast Carcinoma Correlates With Upregulation of Estrogen and Progesterone Receptor Expression in the Primary Tumor.	ESR1 PGR	2.84e-05	2	186	2	27479811
Pubmed	A correlation between the expression of estrogen receptors and progesterone receptors in cancer cells and in the myometrium and prognostic factors in endometrial cancer.	ESR1 PGR	2.84e-05	2	186	2	24851606
Pubmed	Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.	ESR1 PGR	2.84e-05	2	186	2	24684970
Pubmed	Ulipristal Acetate Antagonizes the Inhibitory Effect of Progesterone on Ciliary Beat Frequency and Upregulates Steroid Receptor Expression Levels in Human Fallopian Tubes.	ESR1 PGR	2.84e-05	2	186	2	26045548
Pubmed	The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis.	ESR1 NCOR2	2.84e-05	2	186	2	24971610
Pubmed	Expression of estrogen and progesterone receptors in smooth muscle metaplasia of rectovaginal endometriosis.	ESR1 PGR	2.84e-05	2	186	2	17413977
Pubmed	Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.	ESR1 PGR	2.84e-05	2	186	2	22092403
Pubmed	Cadmium, cobalt and lead cause stress response, cell cycle deregulation and increased steroid as well as xenobiotic metabolism in primary normal human bronchial epithelial cells which is coordinated by at least nine transcription factors.	AKR1C1 AKR1C2	2.84e-05	2	186	2	18654764
Pubmed	Altered expression of hormone receptor, integrin β3 and pinopode in the endometrium of luteal phase defect women.	ESR1 PGR	2.84e-05	2	186	2	27960568
Pubmed	Disrupted PGR-B and ESR1 signaling underlies defective decidualization linked to severe preeclampsia.	ESR1 PGR	2.84e-05	2	186	2	34709177
Pubmed	High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.	ESR1 PGR	2.84e-05	2	186	2	33711637
Pubmed	Effects of phytoestrogen extracts isolated from pumpkin seeds on estradiol production and ER/PR expression in breast cancer and trophoblast tumor cells.	ESR1 PGR	2.84e-05	2	186	2	23859042
Pubmed	Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk.	ESR1 PGR	2.84e-05	2	186	2	18798271
Pubmed	Mammary epithelial cells of PR-A transgenic mice exhibit distinct alterations in gene expression and growth potential associated with transformation.	ESR1 PGR	2.84e-05	2	186	2	12663498
Pubmed	The correlation of estrogen receptor 1 and progesterone receptor genes polymorphisms with recurrent pregnancy loss in a cohort of Egyptian women.	ESR1 PGR	2.84e-05	2	186	2	34061327
Pubmed	The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.	AKR1C1 AKR1C2	2.84e-05	2	186	2	26934124
Pubmed	Comparing expression of progesterone and estrogen receptors in testicular tissue from men with obstructive and nonobstructive azoospermia.	ESR1 PGR	2.84e-05	2	186	2	18835831
Pubmed	Oviductal estrogen receptor α signaling prevents protease-mediated embryo death.	AMHR2 ESR1	2.84e-05	2	186	2	26623518
Pubmed	[The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial cancer].	ESR1 PGR	2.84e-05	2	186	2	23668054
Pubmed	[Expression of ER alpha and SMRT in apoptosis of breast cancer cells induced by tamoxifen].	ESR1 NCOR2	2.84e-05	2	186	2	18546531
Pubmed	Long-range transcriptional control of progesterone receptor gene expression.	ESR1 PGR	2.84e-05	2	186	2	19952285
Pubmed	Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma.	ESR1 PGR	2.84e-05	2	186	2	36208382
Pubmed	Estrogen Receptor α Regulates Dlx3-Mediated Osteoblast Differentiation.	ESR1 DLX3	2.84e-05	2	186	2	26674964
Pubmed	Association of progesterone receptor with migraine-associated vertigo.	ESR1 PGR	2.84e-05	2	186	2	17609999
Pubmed	Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.	ESR1 PGR	2.84e-05	2	186	2	28912152
Pubmed	Estrogen receptor alpha and progesterone receptor A and B concentration and localization in the lower uterine segment in term parturition.	ESR1 PGR	2.84e-05	2	186	2	12113882
Pubmed	Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas.	ESR1 PGR	2.84e-05	2	186	2	19367380
Pubmed	Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.	ESR1 PGR	2.84e-05	2	186	2	23977306
Pubmed	Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.	AKR1C1 AKR1C2	2.84e-05	2	186	2	15492289
Pubmed	The expression of ER, PR in endometrial cancer and analysis of their correlation with ERK signaling pathway.	ESR1 PGR	2.84e-05	2	186	2	29081408
Pubmed	Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.	ESR1 NCOR2	2.84e-05	2	186	2	9171229
Pubmed	Juxtacrine Activity of Estrogen Receptor α in Uterine Stromal Cells is Necessary for Estrogen-Induced Epithelial Cell Proliferation.	AMHR2 ESR1	2.84e-05	2	186	2	28827707
Pubmed	A comparison of oestrogen receptor and progesterone receptor expression in endometrial polyps and endometrium of premenopausal women.	ESR1 PGR	2.84e-05	2	186	2	19835506
Cytoband	4q35.2	DUX4L2 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	1.12e-09	27	186	6	4q35.2
Cytoband	5q31	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P	2.55e-08	115	186	8	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr4q35	DUX4L9 DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	2.92e-08	117	186	8	chr4q35
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P KCTD16	4.01e-06	298	186	9	chr5q31
Cytoband	10p15-p14	AKR1C1 AKR1C2	2.42e-04	6	186	2	10p15-p14
GeneFamily	Clustered protocadherins	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2 PCDHB8 PCDHB6 PCDHB2 PCDHB18P	2.90e-08	64	138	8	20
GeneFamily	PRD class homeoboxes and pseudogenes	DUX4L9 DUX4L2 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	6.61e-06	92	138	7	521
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	APOH HPR VCAN SEZ6	9.38e-04	57	138	4	1179
Coexpression	SMID_BREAST_CANCER_LUMINAL_A_UP	CILP ESR1 RBP4 LAMA2 PGR LIPE CHRDL1 COL14A1	1.60e-07	85	185	8	M7517
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL	TCTN3 DCHS2 DNPH1 ITGA9 GDF10 AKR1C1 AKR1C2 SLC5A3 SULF2 SCNN1B CHRDL1 AK4 C1QTNF4 SMAD9	1.13e-06	402	185	14	M45754
Coexpression	DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS	CILP CD248 ISLR PGR SULF2 ADRA2C CHRD CHRDL1	2.00e-06	118	185	8	M40281
Coexpression	DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS	CILP CD248 PCDHGB6 ISLR PGR SULF2 ADRA2C ADAMTS15 CHRDL1	5.67e-06	180	185	9	M40135
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	TMEM30B AKR1C1 AKR1C2 LIPE ADRA2C PTPRR LPL	8.17e-06	102	185	7	MM872
Coexpression	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	AKNA CHRNE SNAP29 BCL2L12 MGAT2 LIPE RAPGEF3 ARHGEF2 NYAP1	1.32e-05	200	185	9	M7911
Coexpression	BENPORATH_ES_WITH_H3K27ME3	TMEM30B DCHS2 SFTPC ESR1 RBP4 PARD3B KCNK4 PGR HOXA6 NT5C1A FOXD4L1 EGR4 LPL CYP26C1 NIM1K ADAMTS15 CHRD CHRDL1 DLX3 RTN4RL2 CDH4 SEZ6	1.38e-05	1115	185	22	M10371
Coexpression	BOQUEST_STEM_CELL_UP	CYBRD1 CILP LAMA2 ISLR GDF10 AKR1C1 SLC5A3 VCAN CHRDL1 COL14A1	1.77e-05	261	185	10	M1834
Coexpression	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	RBP4 AKR1C1 LIPE RAPGEF3 LPL CHRDL1	3.14e-05	85	185	6	M1451
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	FRAS1 PDE3A IRF7 INPP4B SLC5A3 HOXA6 HELZ2 SLC9A7	4.95e-05	183	185	8	M6670
Coexpression	GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP	PTBP2 SCAMP1 NBEA GTF2IRD1 BRWD3 RUSC2 MGAT5 CEP170B	5.76e-05	187	185	8	M6807
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL	CAMSAP3 HID1 AKR1C1 AKR1C2 TG CORO1A PTPRN PTPRR ZFR2 SLC9A7 NYAP1	7.78e-05	375	185	11	M45799
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CILP CD248 PCDHGB2 ESR1 RBP4 LAMA2 GDF10 PTPRN ZFR2 CHRD SMAD9	5.60e-10	198	180	11	7d2fe57e0f9311ac1e6854402ebc154306eb1ba5
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SHANK1 B3GNT9 CILP CD248 LAMA2 ISLR GDF10 GK5 CHRD COL14A1	4.51e-09	185	180	10	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 ITGA9 DIPK2B LIPE SULF2 CFAP161 PREX1 GARRE1 SMAD9	8.24e-09	197	180	10	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 ITGA9 DIPK2B LIPE SULF2 CFAP161 PREX1 GARRE1 SMAD9	8.24e-09	197	180	10	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CILP CD248 LAMA2 ISLR GDF10 PGR PTPRN CHRDL1 COL14A1	8.86e-08	191	180	9	0fae1c2ef9f83ac7721d0a9d69455bf97eed9257
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 RBP4 LAMA2 ISLR GDF10 SULF2 VCAN CHRD COL14A1	9.26e-08	192	180	9	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD248 RBP4 LAMA2 ISLR GDF10 SULF2 VCAN CHRD COL14A1	9.26e-08	192	180	9	7b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 RBP4 LAMA2 ISLR GDF10 SULF2 VCAN CHRD COL14A1	9.26e-08	192	180	9	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD248 RBP4 LAMA2 ISLR GDF10 SULF2 VCAN CHRD COL14A1	9.26e-08	192	180	9	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CILP CD248 RBP4 LAMA2 ISLR GDF10 SULF2 VCAN COL14A1	9.26e-08	192	180	9	011634a24b0c61d9b463fe755502edbc5cd70b7a
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 PCDHGB2 LAMA2 ISLR GDF10 MST1R COL14A1 SMAD9	9.68e-08	193	180	9	59b8186d0221fba06a16157e9d148399ed801f38
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 RBP4 LAMA2 ISLR GDF10 VCAN ADAMTS15 CHRD COL14A1	9.68e-08	193	180	9	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 PCDHGB2 LAMA2 ISLR GDF10 MST1R COL14A1 SMAD9	9.68e-08	193	180	9	dc92680b4bb9fc26430c92e03adb839c8c3b3b98
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 PCDHGB2 LAMA2 ISLR GDF10 MST1R COL14A1 SMAD9	9.68e-08	193	180	9	03678162648bd5b1d65a5450b60c8863edbf95c7
ToppCell	facs-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 CHRNE MST1R VCAN CYP26C1 COL14A1	1.01e-07	194	180	9	fcd5e9238d299c41f0bf9693b56cd8c900d2112b
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 CHRNE MST1R VCAN CYP26C1 COL14A1	1.01e-07	194	180	9	bbc625b4cc53bb7d6254fde287258e51f9171572
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 CHRNE MST1R VCAN CYP26C1 COL14A1	1.01e-07	194	180	9	6afc21c5fec30ab8e373e3e46ab7866204c805b6
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBRD1 CILP CD248 ESR1 LAMA2 ISLR VCAN CHRDL1 COL14A1	1.06e-07	195	180	9	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 RBP4 LAMA2 ISLR ITGA9 GDF10 SULF2 VCAN COL14A1	1.10e-07	196	180	9	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 RBP4 LAMA2 ISLR ITGA9 GDF10 SULF2 VCAN COL14A1	1.10e-07	196	180	9	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-E\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	TMEM30B CYBRD1 CILP LAMA2 ISLR AKR1C1 CHRDL1 COL14A1 SMAD9	1.15e-07	197	180	9	9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0
ToppCell	Biopsy_IPF-Mesenchymal-Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	CYBRD1 CILP CD248 LAMA2 ISLR GDF10 CHRD CHRDL1 COL14A1	1.31e-07	200	180	9	d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYBRD1 CILP CD248 LAMA2 ISLR AKR1C1 VCAN CHRDL1 COL14A1	1.31e-07	200	180	9	fc3c4778841c4b8bac0afb458352614b2c460617
ToppCell	367C-Fibroblasts-Fibroblast-D-\|367C / Donor, Lineage, Cell class and subclass (all cells)	CYBRD1 CD248 LAMA2 ISLR GDF10 AKR1C1 CHRDL1 COL14A1	2.23e-07	154	180	8	dd3d34f065820e706515a13619f19a5b12734c8e
ToppCell	367C-Fibroblasts-Fibroblast-D\|367C / Donor, Lineage, Cell class and subclass (all cells)	CYBRD1 CD248 LAMA2 ISLR GDF10 AKR1C1 CHRDL1 COL14A1	2.23e-07	154	180	8	4bfda1c41efbb86d829b3797d1168bf2587c3c97
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM46 CAMSAP3 PCDHB2 PTPRN VCAN KBTBD13 C1QTNF4 SEZ6	5.41e-07	173	180	8	2b448acd5e584f24567204c31b8d74715e92f32a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM46 CAMSAP3 PCDHB2 PTPRN VCAN KBTBD13 C1QTNF4 SEZ6	5.41e-07	173	180	8	5086edc29c5a6137ca09877929a1317f9739c801
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYBRD1 CILP CD248 PCDHGA2 LAMA2 ISLR CHRDL1 COL14A1	5.65e-07	174	180	8	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYBRD1 CILP CD248 PCDHGA2 LAMA2 ISLR CHRDL1 COL14A1	5.65e-07	174	180	8	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF703 CYBRD1 CD248 LAMA2 ISLR VCAN LYPD3 COL14A1	6.16e-07	176	180	8	fcf324e6402819683f95e0dd94bf1f777c7f4c76
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF703 CYBRD1 CD248 LAMA2 ISLR VCAN LYPD3 COL14A1	7.00e-07	179	180	8	68ccfe66474d049a926afc21bffa231446becc69
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF703 CYBRD1 CD248 ISLR PGR ADRA2C VCAN COL14A1	7.30e-07	180	180	8	ea7a1ccf0dd3bb5af5df87501f873e7339a824b3
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CILP CD248 RBP4 LAMA2 ISLR GDF10 VCAN COL14A1	7.30e-07	180	180	8	9adebde5f4ca6dcb90e9113622862e14298465ac
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CILP CD248 RBP4 LAMA2 ISLR GDF10 VCAN COL14A1	7.93e-07	182	180	8	e9fcae9d03a6faf85b91882c5da699037bc61aeb
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD248 PCDHGB6 ISLR VCAN ADAMTS15 COL14A1 DLX3 CDH4	8.27e-07	183	180	8	07ca2786e62eca9feecf5e54a11864a960f7641a
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	B3GNT9 CILP RBP4 LAMA2 ISLR GDF10 SULF2 COL14A1	8.62e-07	184	180	8	01257e5c12e38b849fd3d9496c43ded666249ba5
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A CYBRD1 CD248 ISLR ITGA9 RUSC2 VCAN SP5	8.62e-07	184	180	8	fea4fe648e9749177d0783443dc26a7df5807883
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A CYBRD1 CD248 ISLR ITGA9 RUSC2 VCAN SP5	8.62e-07	184	180	8	96a8a0a190bc293655fe7d80cbed8119c0da25f2
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A CYBRD1 CD248 ISLR ITGA9 RUSC2 VCAN SP5	8.62e-07	184	180	8	780eb72da43527f0c72effac3423ec7384f05f20
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	B3GNT9 CD248 RBP4 LAMA2 ISLR GDF10 SULF2 COL14A1	9.35e-07	186	180	8	c0a036096c2cb23305605b8aaf18869d6e0fb512
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 ZNF366 SULF2 PTPRR RAPGEF3 CFAP161 ADGRL2 SMAD9	9.73e-07	187	180	8	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CILP CD248 RBP4 LAMA2 ISLR VCAN COL14A1 DLX3	1.01e-06	188	180	8	bba6b273bd47dd0e27fde914e9e6fc9d76fd5176
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 CILP CD248 RBP4 LAMA2 ISLR GDF10 COL14A1	1.10e-06	190	180	8	f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a
ToppCell	droplet-Kidney-nan-3m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 CILP CD248 RBP4 LAMA2 ISLR GDF10 COL14A1	1.10e-06	190	180	8	2abeb013bb83c578e67dcb985ba44ca63134950b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ESR1 LAMA2 ITGA9 INPP4B PGR VCAN COL14A1	1.14e-06	191	180	8	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 CILP CD248 RBP4 LAMA2 ISLR GDF10 COL14A1	1.14e-06	191	180	8	d1205aab0937f2becfcd239610e9b78fb8a0c886
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ESR1 LAMA2 ITGA9 INPP4B PGR VCAN COL14A1	1.14e-06	191	180	8	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CILP CD248 RBP4 LAMA2 ISLR GDF10 CHRDL1 COL14A1	1.14e-06	191	180	8	24dc77ee8de01b42559f92721655f4281b114e17
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CILP CD248 RBP4 LAMA2 ISLR GDF10 CHRD COL14A1	1.19e-06	192	180	8	c3707243c5590d852c9f28429c96f50a1fa6b0dc
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 MST1R VCAN ADAMTS15 COL14A1	1.19e-06	192	180	8	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HID1 AKR1C1 AKR1C2 DIPK2B SULF2 SCNN1B CHRDL1 BAIAP2	1.19e-06	192	180	8	5388f3115ab285f3f3001af1d71543ed64b9e044
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD248 LAMA2 ISLR GDF10 KCNK4 PGR CHRDL1 COL14A1	1.19e-06	192	180	8	b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 MST1R VCAN ADAMTS15 COL14A1	1.19e-06	192	180	8	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	B3GNT9 CILP CD248 RBP4 LAMA2 ISLR GDF10 COL14A1	1.19e-06	192	180	8	29bee88b45e23f16543ffc7cc361bc5da5d16a2b
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 MST1R VCAN ADAMTS15 COL14A1	1.19e-06	192	180	8	ac1477433704573f95111eee6263b93668d2845e
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	B3GNT9 CILP CD248 RBP4 LAMA2 ISLR GDF10 COL14A1	1.19e-06	192	180	8	cdc652dbfabe41b324fd85c1ed933d29fb73a49f
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 LAMA2 ISLR SULF2 VCAN LPL COL14A1	1.23e-06	193	180	8	160691b671710be10220803d788c2c961c236af1
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CILP CD248 RBP4 LAMA2 ISLR GK5 CHRDL1 COL14A1	1.23e-06	193	180	8	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HID1 AKR1C1 AKR1C2 DIPK2B SULF2 SCNN1B CHRDL1 BAIAP2	1.23e-06	193	180	8	ef007b736da56529ec628fc3df86a335e7ec3f18
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMA2 ISLR GDF10 SULF2 VCAN COL14A1 CDH4	1.28e-06	194	180	8	3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD248 LAMA2 ISLR GDF10 SULF2 VCAN COL14A1 CDH4	1.28e-06	194	180	8	ff19fb5bc7feae3e774ef4ab720beb9dec219f45
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYBRD1 CD248 LAMA2 ISLR HPR VCAN CHRDL1 COL14A1	1.28e-06	194	180	8	02b8102be9414d6964cd71019613edff6d88b893
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	B3GNT9 CILP CD248 RBP4 LAMA2 ISLR GDF10 COL14A1	1.28e-06	194	180	8	ca1f24070424b44b7a442e4fca761ebfbe24b063
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 LAMA2 ISLR GDF10 SULF2 VCAN COL14A1	1.33e-06	195	180	8	69a29d03e664b72f32d41876510c62345c3aed31
ToppCell	-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CD248 LAMA2 ISLR GDF10 INPP4B CORO1A CHRDL1 COL14A1	1.33e-06	195	180	8	e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBRD1 CILP CD248 LAMA2 ISLR GDF10 CHRDL1 COL14A1	1.33e-06	195	180	8	1236dc60288c7dd91868e86e9174a2dacd3b11b3
ToppCell	facs-GAT-Fat-3m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 LAMA2 ISLR GDF10 SULF2 VCAN COL14A1	1.33e-06	195	180	8	1cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP CD248 LAMA2 ISLR GDF10 SULF2 VCAN COL14A1	1.33e-06	195	180	8	9cef6f18664518060af7c192310dddce6d70345a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CILP CD248 LAMA2 ISLR HPR CHRD CHRDL1 COL14A1	1.44e-06	197	180	8	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FRAS1 LAMA2 PARD3B GDF10 VCAN LPL COL14A1 ADGRL2	1.44e-06	197	180	8	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LAMA2 PARD3B GDF10 VCAN LPL COL14A1 ADGRL2 CDH4	1.44e-06	197	180	8	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLT1 RSPH4A ZNF366 PCDHGA2 HID1 DIPK2B DCHS1 ADGRL2	1.49e-06	198	180	8	122215d9288533ad03562cf777e846504863df9a
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLT1 RSPH4A ZNF366 PCDHGA2 HID1 DIPK2B DCHS1 ADGRL2	1.49e-06	198	180	8	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DCHS2 FRAS1 PLEKHG7 NBEA AKR1C1 INPP4B PTPRR SCNN1B	1.49e-06	198	180	8	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBRD1 CILP CD248 LAMA2 HPR CHRDL1 COL14A1 SPSB4	1.55e-06	199	180	8	1fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD248 LAMA2 ISLR GDF10 AKR1C1 AKR1C2 PGR COL14A1	1.55e-06	199	180	8	dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBRD1 CILP CD248 LAMA2 ISLR HPR CHRDL1 COL14A1	1.55e-06	199	180	8	9672230aa0bc6a7289050c955f5154ca183a5159
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBRD1 CILP CD248 LAMA2 ISLR HPR CHRDL1 COL14A1	1.55e-06	199	180	8	e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCell	distal-2-mesenchymal-Adventitial_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYBRD1 CILP CD248 LAMA2 ISLR GDF10 CHRDL1 COL14A1	1.55e-06	199	180	8	97b475f9110ef7bb29d9cf2109b7e43177830f05
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD248 LAMA2 ISLR GDF10 AKR1C1 AKR1C2 PGR COL14A1	1.55e-06	199	180	8	c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	CILP CD248 LAMA2 ISLR GDF10 CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	8d75ce89393df452defacf2ec9a5bd4b7708afbb
ToppCell	Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	CYBRD1 CILP CD248 LAMA2 ISLR ADAMTS15 CHRDL1 COL14A1	1.61e-06	200	180	8	2c5626ea8fb4b702d4560117e53edf6cfcf1971e
ToppCell	Bronchial-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYBRD1 CILP CD248 LAMA2 ISLR CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	5ea12e17f50fefbf5534e487af3392b2fa2d13ad
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CYBRD1 CILP CD248 LAMA2 ISLR CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	(6)_Stroma\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CILP CD248 LAMA2 ISLR VCAN CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	f0818821c495022569aef2c1886d9f2446dc027e
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	CILP CD248 LAMA2 ISLR VCAN CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYBRD1 CILP CD248 LAMA2 ISLR GDF10 CHRDL1 COL14A1	1.61e-06	200	180	8	6316c288022719b9e6c4332c5cb9041e1188d0e8
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBRD1 CILP CD248 LAMA2 ISLR VCAN CHRDL1 COL14A1	1.61e-06	200	180	8	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	367C-Fibroblasts-Fibroblast-E\|367C / Donor, Lineage, Cell class and subclass (all cells)	CYBRD1 CILP CD248 LAMA2 ISLR AKR1C1 CHRDL1 COL14A1	1.61e-06	200	180	8	ddfbc004e7bd2fd3f11f046ed8fc049277160547
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CYBRD1 CILP CD248 LAMA2 ISLR CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	367C-Fibroblasts-Fibroblast-E-\|367C / Donor, Lineage, Cell class and subclass (all cells)	CYBRD1 CILP CD248 LAMA2 ISLR AKR1C1 CHRDL1 COL14A1	1.61e-06	200	180	8	57b9d6aa2265ab178a5886f36ecc66115bd382a8
ToppCell	(6)_Stroma\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CILP CD248 LAMA2 ISLR VCAN CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	f9baef67dde62f1c161a9408a78f635ea70ea9d3
ToppCell	Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CYBRD1 CILP CD248 LAMA2 ISLR AKR1C1 CHRDL1 COL14A1	1.61e-06	200	180	8	0aa316b71f195ecf17ee897e307f8928a755a637
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBRD1 CILP CD248 LAMA2 ISLR VCAN CHRDL1 COL14A1	1.61e-06	200	180	8	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYBRD1 CILP CD248 LAMA2 ISLR CHRD CHRDL1 COL14A1	1.61e-06	200	180	8	b04831708fa20471a127b87e8db3728b6e729ce8
ToppCell	(5)_Fibroblast-E\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CYBRD1 CILP CD248 LAMA2 ISLR AKR1C1 CHRDL1 COL14A1	1.61e-06	200	180	8	75e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBRD1 CILP CD248 LAMA2 ISLR VCAN CHRDL1 COL14A1	1.61e-06	200	180	8	f6cf98aad53aa8b3fa02cf874d6f7cd75530a213
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB7 SFTPC SULF2 VCAN UGT8 PREX1 PLXNB3	2.65e-06	150	180	7	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 ITGA9 DIPK2B LIPE HELZ2 PREX1	3.30e-06	155	180	7	59035d792c26d870a8b097939e97fa47859ba68c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PDE3A LAMA2 INPP4B PGR NIM1K COL14A1	3.90e-06	159	180	7	e812cbde59188924c6277c3feadf1a9592fa62a4
Disease	obesity (implicated_via_orthology)	DCHS2 DNAH10 ESR1 PUM2 LPIN1 HPR LPL DCHS1 PLXNB3	6.50e-06	215	177	9	DOID:9970 (implicated_via_orthology)
Disease	C-reactive protein measurement	DCHS2 CD248 MBNL1 GBX1 RBKS HID1 APOH GK5 NT5DC1 MST1R TRANK1 HPR LPL CYP26C1 PKD1 SLC9A7 AK4 C1QTNF4 TNFRSF1A CDH4	4.02e-05	1206	177	20	EFO_0004458
Disease	Oligospermia	ESR1 CDC14A PIWIL3	4.49e-05	12	177	3	C0028960
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN PKD1	4.49e-05	12	177	3	DOID:10941 (is_implicated_in)
Disease	Neoplasms, Hormone-Dependent	AKR1C1 AKR1C2	1.07e-04	3	177	2	C0027661
Disease	response to methotrexate	AKR1C1 AKR1C2 INPP4B	1.12e-04	16	177	3	GO_0031427
Disease	Sclerocystic Ovaries	SFTPC RBP4 AKR1C1 AKR1C2 DUX4L5 FUT7	2.41e-04	144	177	6	C1136382
Disease	Polycystic Ovary Syndrome	SFTPC RBP4 AKR1C1 AKR1C2 DUX4L5 FUT7	2.41e-04	144	177	6	C0032460
Disease	Malignant neoplasm of breast	FLT1 PCDHGB6 ZNF366 ESR1 LAMA2 TRAPPC8 ITGA9 GDF10 INPP4B PGR KMT2D LIPE SULF2 PER3 SYNJ2 SCNN1B RUSF1	2.70e-04	1074	177	17	C0006142
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	DNAH10 APOH NCOR2 PPP2R3A MGAT5 HPR LPL	3.33e-04	215	177	7	EFO_0008317, EFO_0008591
Disease	Hermaphroditism	AKR1C1 AKR1C2	3.54e-04	5	177	2	C0019269
Disease	Ambiguous Genitalia	AKR1C1 AKR1C2	3.54e-04	5	177	2	C0266362
Disease	Pseudohermaphroditism	AKR1C1 AKR1C2	3.54e-04	5	177	2	C0033804
Disease	Intersex Conditions	AKR1C1 AKR1C2	3.54e-04	5	177	2	C2930618
Disease	Sex Differentiation Disorders	AKR1C1 AKR1C2	3.54e-04	5	177	2	C2930619
Disease	obesity (is_marker_for)	RBP4 AKR1C1 AKR1C2 PLAUR TNFRSF1A	3.65e-04	101	177	5	DOID:9970 (is_marker_for)
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 APOH NCOR2 PPP2R3A MGAT5 HPR LPL	3.82e-04	220	177	7	EFO_0004529, EFO_0008317
Disease	aspartate aminotransferase measurement	TRIM46 PDE3A ZNF366 PLEKHG7 MBNL1 AKNA APOH ITGA9 INPP4B LPIN1 NCOR2 MGAT5 PTPRR HPR C1QTNF4	3.83e-04	904	177	15	EFO_0004736
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	DNAH10 APOH NCOR2 PPP2R3A MGAT5 HPR LPL	4.37e-04	225	177	7	EFO_0008317, EFO_0010351
Disease	mental development measurement	PCDHGB6 PCDHGB2 PCDHGA2	4.43e-04	25	177	3	EFO_0008230
Disease	Carcinomatosis	ESR1 RBP4 PGR CORO1A LPL PLAUR	4.67e-04	163	177	6	C0205699
Disease	Carcinoma, Spindle-Cell	ESR1 RBP4 PGR CORO1A LPL PLAUR	4.67e-04	163	177	6	C0205697
Disease	Undifferentiated carcinoma	ESR1 RBP4 PGR CORO1A LPL PLAUR	4.67e-04	163	177	6	C0205698
Disease	Anaplastic carcinoma	ESR1 RBP4 PGR CORO1A LPL PLAUR	4.67e-04	163	177	6	C0205696
Disease	Carcinoma	ESR1 RBP4 PGR CORO1A LPL PLAUR	4.82e-04	164	177	6	C0007097
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	DNAH10 APOH NCOR2 PPP2R3A MGAT5 HPR LPL	4.86e-04	229	177	7	EFO_0004639, EFO_0008317
Disease	lean body mass	PDE3A CYBRD1 ESR1 LAMA2 PARD3B MST1R NCOR2 VCAN BAIAP2	4.99e-04	379	177	9	EFO_0004995
Disease	endometriosis (is_implicated_in)	ESR1 PGR	5.28e-04	6	177	2	DOID:289 (is_implicated_in)
Disease	leiomyosarcoma (is_marker_for)	AMHR2 FLT1	5.28e-04	6	177	2	DOID:1967 (is_marker_for)
Disease	osteoarthritis (is_implicated_in)	CILP ESR1 NCOR2	6.23e-04	28	177	3	DOID:8398 (is_implicated_in)
Disease	platelet measurement	REST INPP4B CHRNE CHRD AK4 MICA TNFRSF1A NYAP1	6.62e-04	315	177	8	EFO_0005036
Disease	neutrophil count	SNX24 ZNF366 KDM5C MBNL1 REST CDC14A OTUD7B MST1R RRP12 PKD1 SLC9A7 CHRDL1 AK4 SPSB4 PLAUR MICA ADGRL2 TAP2 PREX1	6.73e-04	1382	177	19	EFO_0004833
Disease	birth measurement, spontaneous preterm birth	ADGRL2 SMAD9	7.37e-04	7	177	2	EFO_0006917, EFO_0006921
Disease	Disorders of Sex Development	AKR1C1 AKR1C2	7.37e-04	7	177	2	C0036875
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA2	8.89e-04	71	177	4	EFO_0007878, EFO_0007979
Disease	Leydig cell tumor (is_marker_for)	FLT1 ESR1	9.78e-04	8	177	2	DOID:2696 (is_marker_for)
Disease	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	KDM5C BRWD3	9.78e-04	8	177	2	C0796250
Disease	very low density lipoprotein cholesterol measurement	DNAH10 APOH NCOR2 PPP2R3A MGAT5 HPR LPL	1.02e-03	260	177	7	EFO_0008317
Disease	Sarcomatoid Renal Cell Carcinoma	SHANK1 FLT1 KDM5C INPP4B SLC5A3	1.07e-03	128	177	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	SHANK1 FLT1 KDM5C INPP4B SLC5A3	1.07e-03	128	177	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	SHANK1 FLT1 KDM5C INPP4B SLC5A3	1.07e-03	128	177	5	C1266044
Disease	Papillary Renal Cell Carcinoma	SHANK1 FLT1 KDM5C INPP4B SLC5A3	1.07e-03	128	177	5	C1306837
Disease	Renal Cell Carcinoma	SHANK1 FLT1 KDM5C INPP4B SLC5A3	1.07e-03	128	177	5	C0007134
Disease	refractive error, age at onset, Myopia	FLT1 PDE3A ZNF366 LAMA2 NT5DC1 PTPRR	1.13e-03	193	177	6	EFO_0004847, HP_0000545, MONDO_0004892
Disease	Pulmonary Cystic Fibrosis	SCNN1B TNFRSF1A	1.25e-03	9	177	2	C0392164
Disease	Fibrocystic Disease of Pancreas	SCNN1B TNFRSF1A	1.25e-03	9	177	2	C1527396
Disease	type 2 diabetes mellitus (is_marker_for)	RBP4 APOH LIPE LPL PLAUR	1.40e-03	136	177	5	DOID:9352 (is_marker_for)
Disease	platelet glycoprotein ib alpha chain measurement	CHRNE AK4	1.56e-03	10	177	2	EFO_0020645
Disease	Breast Carcinoma	FLT1 PCDHGB6 ZNF366 ESR1 GDF10 INPP4B PGR KMT2D PER3 SYNJ2	1.60e-03	538	177	10	C0678222
Disease	Animal Mammary Neoplasms	ESR1 RBP4 PGR CORO1A LPL	1.70e-03	142	177	5	C0024667
Disease	Mammary Carcinoma, Animal	ESR1 RBP4 PGR CORO1A LPL	1.70e-03	142	177	5	C1257925
Disease	testosterone measurement	ZNF703 DCHS2 ESR1 MBNL1 AKNA APOH GTF2IRD1 AKR1C2 NCOR2 LIPE MGAT5 PER3 CYP26C1 UGT8 CHRDL1 ADGRL2 SGF29	1.79e-03	1275	177	17	EFO_0004908
Disease	influenza A (H1N1)	ZNF703 GTF2IRD1 PTPRR ADGRL2	1.89e-03	87	177	4	EFO_1001488
Disease	Cystic Fibrosis	SCNN1B TNFRSF1A	1.90e-03	11	177	2	C0010674
Disease	Mesothelioma	ESR1 GDF10 PGR	1.91e-03	41	177	3	C0025500
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DNAH10 APOH SULF2 LPL HELZ2 PLAUR MICA	1.95e-03	291	177	7	EFO_0008317, EFO_0020946
Disease	obesity (biomarker_via_orthology)	PDE3A RBP4 LIPE HPR LPL	1.97e-03	147	177	5	DOID:9970 (biomarker_via_orthology)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	SHANK1 FLT1 KDM5C INPP4B SLC5A3	2.03e-03	148	177	5	C0279702
Disease	platelet component distribution width	VPS18 INPP4B CHRNE NCOR2 TRANK1 SYNJ2 RAPGEF3 LPL MICA NYAP1 TAP2 PREX1	2.10e-03	755	177	12	EFO_0007984
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	APOH CTAGE1 LPL PLAUR MICA	2.16e-03	150	177	5	EFO_0004611, EFO_0020947
Disease	taurodeoxycholate measurement	MBNL1 CDC14A	2.27e-03	12	177	2	EFO_0010539
Disease	macular retinal edema (is_marker_for)	FLT1 APOH	2.27e-03	12	177	2	DOID:4449 (is_marker_for)
Disease	autism spectrum disorder (implicated_via_orthology)	SHANK1 SCAMP1 KDM5C NBEA PREX1	2.28e-03	152	177	5	DOID:0060041 (implicated_via_orthology)
Disease	psoriasis (is_marker_for)	FLT1 RBP4 TNFRSF1A	2.35e-03	44	177	3	DOID:8893 (is_marker_for)
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	DNAH10 APOH NCOR2 PPP2R3A HPR LPL	2.39e-03	224	177	6	EFO_0004574, EFO_0008317
Disease	colon carcinoma (is_marker_for)	KMT2D TNFRSF1A	2.67e-03	13	177	2	DOID:1520 (is_marker_for)
Disease	pneumonia	HELZ2 MICA TNFRSF1A	2.83e-03	47	177	3	EFO_0003106
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PDE3A DNAH10 ZNF366 APOH NCOR2 SULF2 LPL	2.87e-03	312	177	7	EFO_0004612, EFO_0010351
Disease	Endometrioma	AKR1C1 AKR1C2 PGR SULF2 VCAN	2.93e-03	161	177	5	C0269102
Disease	Endometriosis	AKR1C1 AKR1C2 PGR SULF2 VCAN	2.93e-03	161	177	5	C0014175
Disease	Male sterility	ESR1 CDC14A KMT2D	3.01e-03	48	177	3	C0917731
Disease	Male infertility	ESR1 CDC14A KMT2D	3.01e-03	48	177	3	C0021364
Disease	Subfertility, Male	ESR1 CDC14A KMT2D	3.01e-03	48	177	3	C0848676
Disease	FEV/FEC ratio	DCHS2 FRAS1 FLT1 PDE3A SFTPC REST GTF2IRD1 NT5DC1 INPP4B OTUD7B TG CORO1A MGAT5 LGALSL CTAGE1 CHRDL1	3.06e-03	1228	177	16	EFO_0004713
Disease	lentiform nucleus measurement	FMO6P DENND4B	3.11e-03	14	177	2	EFO_0004913
Disease	lymphocyte count	TCTN3 FRAS1 PCDHGB7 DNAH10 PCDHGB6 PCDHGB2 PCDHGA2 MBNL1 REST TDRD1 INPP4B HOXA6 MST1R PLAUR MICA TNFRSF1A FUT7 PREX1	3.16e-03	1464	177	18	EFO_0004587
Disease	developmental disorder of mental health (implicated_via_orthology)	PARD3B NCOR2 PLXNB3	3.19e-03	49	177	3	DOID:0060037 (implicated_via_orthology)
Disease	Colorectal Carcinoma	SHANK1 EPHB6 VPS18 CD248 ISLR CDC14A LPIN1 DCHS1 SCNN1B ADAMTS15 SMAD9	3.55e-03	702	177	11	C0009402
Disease	refractive error	FLT1 LAMA2 NBEA NT5DC1 PTPRR SGF29 NYAP1	3.65e-03	326	177	7	MONDO_0004892
Disease	colorectal cancer	MBNL1 INPP4B SYNJ2 PTPRR VCAN UGT8 MICA PREX1 GARRE1 SMAD9	3.66e-03	604	177	10	MONDO_0005575
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	DNAH10 SULF2 HPR LPL	4.00e-03	107	177	4	EFO_0004614, EFO_0004615
Disease	proliferative diabetic retinopathy (is_marker_for)	FLT1 RBP4	4.06e-03	16	177	2	DOID:13207 (is_marker_for)
Disease	Congestive heart failure	RBP4 ADRA2C PIK3CG TNFRSF1A	4.41e-03	110	177	4	C0018802
Disease	Heart failure	RBP4 ADRA2C PIK3CG TNFRSF1A	4.41e-03	110	177	4	C0018801
Disease	Left-Sided Heart Failure	RBP4 ADRA2C PIK3CG TNFRSF1A	4.41e-03	110	177	4	C0023212
Disease	Heart Failure, Right-Sided	RBP4 ADRA2C PIK3CG TNFRSF1A	4.41e-03	110	177	4	C0235527
Disease	Heart Decompensation	RBP4 ADRA2C PIK3CG TNFRSF1A	4.41e-03	110	177	4	C1961112
Disease	Myocardial Failure	RBP4 ADRA2C PIK3CG TNFRSF1A	4.41e-03	110	177	4	C1959583
Disease	triglycerides in medium VLDL measurement	DNAH10 HPR LPL	4.43e-03	55	177	3	EFO_0022155
Disease	factor VII activating protease measurement	HELZ2 TSPYL5 DLX3	4.43e-03	55	177	3	EFO_0009368
Disease	Graves disease, thyrotoxic periodic paralysis	DCHS2 MICA	4.59e-03	17	177	2	EFO_0004237, MONDO_0019201
Disease	Night blindness, congenital stationary	RBP4 GRK1	4.59e-03	17	177	2	C0339535
Disease	ischemia (implicated_via_orthology)	SCNN1B TNFRSF1A	4.59e-03	17	177	2	DOID:326 (implicated_via_orthology)
Disease	Mammary Carcinoma, Human	FLT1 PCDHGB6 ZNF366 ESR1 GDF10 PGR KMT2D PER3 SYNJ2	4.60e-03	525	177	9	C4704874
Disease	Mammary Neoplasms, Human	FLT1 PCDHGB6 ZNF366 ESR1 GDF10 PGR KMT2D PER3 SYNJ2	4.60e-03	525	177	9	C1257931
Disease	triglycerides in large VLDL measurement	DNAH10 APOH LPL	4.66e-03	56	177	3	EFO_0022178
Disease	lipoprotein A measurement	APOH SYNJ2 HPR LPL	4.70e-03	112	177	4	EFO_0006925
Disease	Mammary Neoplasms	FLT1 PCDHGB6 ZNF366 ESR1 GDF10 PGR KMT2D PER3 SYNJ2	4.71e-03	527	177	9	C1458155
Disease	calcium measurement	TRIM46 PDE3A MBNL1 NT5DC1 CHRNE LYPD3 UGT8 AK4 C1QTNF4 FER1L5	4.80e-03	628	177	10	EFO_0004838
Disease	platelet crit	SNX24 SCAMP1 MAP3K14 REST APOH CHRNE DCHS1 CHRD CHRDL1 AK4 PLAUR TNFRSF1A PREX1	5.05e-03	952	177	13	EFO_0007985

Protein segments in the cluster

Peptide	Gene	Start	Entry
CDQLPPRSDFYPAIG	TDRD1	531	Q9BXT4
PFPSRPDNGFVNYPA	APOH	206	P02749
LRDPAYSTFPPEGVF	CYBRD1	186	Q53TN4
YRFENQTGFPPPDSR	VCAN	326	P13611
VFGASPDYFSPRDVP	CTAGE1	696	Q96RT6
RYFEADPPGQVAASP	DNPH1	156	O43598
RYQLEHENEPFSPGP	NT5C1A	81	Q9BXI3
GSNPPYLPFRDASFG	CDC14A	121	Q9UNH5
QPAPARGDFAYAAPA	DUX4L4	231	P0CJ87
PLVSLYRQPDGAAYP	ADRA2C	186	P18825
DALYLSFNPPQPSRG	ARHGEF2	891	Q92974
TQPPDFALAYRPSFP	CD248	401	Q9HCU0
NYPDGDCPRLVFDIP	AKTIP	131	Q9H8T0
PAPYDEEPFQAPALF	ARHGEF33	626	A8MVX0
VYADADADAPARGPP	C1QTNF4	156	Q9BXJ3
FSGFLVYPDLAPAAP	C1QTNF4	306	Q9BXJ3
EPGPATPDFYALVAQ	BCL2L12	166	Q9HB09
DSEPFRQPADLLSYP	BRWD3	1321	Q6RI45
LRYSLEFGPPDPAQV	ADGRL2	386	O95490
PSTPVNARYEFGPAL	CLDN19	151	Q8N6F1
SDLFQEDLYPPTAGP	CORO1A	356	P31146
AFPDPQLRLEYEGFP	CFAP161	196	Q6P656
QPAPARGDFAYAAPA	DUX4L6	231	P0CJ89
PAEPQGCSFRREPSY	CEP170B	211	Q9Y4F5
AQPSPPARDGVYVSA	CEP170B	826	Q9Y4F5
FRDEAFPPVPQSLGY	CAPN1	56	P07384
RPLQEFYDAPPDQAA	DIPK2B	251	Q9H7Y0
APADGAAPAQPSIRY	CAMSAP3	196	Q9P1Y5
GAYREQPLPAQDPVS	DLX3	96	O60479
GAEYVISPLPNASAP	ADAMTS15	131	Q8TE58
LFNNYDPGSRPVREP	CHRNE	31	Q04844
SSPPPFQLAYEAELG	AMHR2	431	Q16671
EAGAPPADPSTLYRD	RTN4RL2	336	Q86UN3
NDNAPEILYPAFPTD	PCDHGA2	556	Q9Y5H1
AAATLAGPAVVPPQY	PUM2	331	Q8TB72
NDNAPRVLYPALGPD	PCDHGB6	556	Q9Y5F9
NDNAPRVLYPALGPD	PCDHGB7	556	Q9Y5F8
DGFSQPYLLLPEAAP	PCDHB2	666	Q9Y5E7
EGFSQPYLPLTEAAP	PCDHB18P	611	Q96TA0
SSVELGRYPALPFPA	KIAA1549	1656	Q9HCM3
FAPPGAAAEPHSLRY	MICA	16	Q29983
FNPAPAIADLDPQFY	RBKS	176	Q9H477
VADSYSNGYREPPEP	OTUD7B	771	Q6GQQ9
PRQSPLTYEDHGAPF	NCOR2	1536	Q9Y618
PENPEPGAALYTFRA	DCHS1	1446	Q96JQ0
QYASLPRGGPADPVD	PARD3B	1081	Q8TEW8
ADPVDYLPAAPRGLY	PARD3B	1091	Q8TEW8
PQPVFEASGAPDIYS	REST	121	Q13127
YGDLPGPSPAQLFQD	PTPRN	261	Q16849
RGEEQSAIPYFPFIP	LGALSL	106	Q3ZCW2
AGYYPNPPLVLSSDE	NT5DC1	436	Q5TFE4
ALGPGYDRPFQFDPS	FRAS1	3401	Q86XX4
PLYQAGYDALRPFPA	HOXA6	26	P31267
ESPSPAYLLFGDRPQ	MAGEB18	36	Q96M61
QPAPARGDFAYAAPA	DUX4	231	Q9UBX2
IQLYPNEFPGSDPRD	MGAT2	181	Q10469
YPREQGSAVPNSFPE	KCTD16	11	Q68DU8
GFPYEGPAPLEAIAN	MGAT5	516	Q09328
GADPRQDSPAYQPLV	KCNK4	221	Q9NYG8
PSGRVYNLDFNPPHV	AK4	131	P27144
DDRFPKPPEIANGYV	HPR	31	P00739
ASVAAFRPLPGFSPY	DHRS4L1	171	P0CG22
PPPEVGRSFLGYASF	INPP4B	136	O15327
VTLQRYDPFPAGDPE	GDF10	261	P55107
QPAPARGDFAYAAPA	DUX4L3	231	P0CJ86
CAYRDLESVPPGFPA	ISLR	36	O14498
AFPLPAATSPGREYA	PER3	801	P56645
LGPVQYEAEPPLSAF	PLXNB3	1236	Q9ULL4
VREAGPPAFYRPNSD	ESR1	141	P03372
PGERTPELNSYPRFS	KSR1	96	Q8IVT5
GLDPAGPNFEYAEAP	LPL	181	P06858
GPNFEYAEAPSRLSP	LPL	186	P06858
NDNAPRVLYPALGPD	PCDHGB2	556	Q9Y5G2
PYSQGNPADEPLERS	PDE3A	591	Q14432
PYSGPRTPDGREINF	PDE6A	301	P16499
GPPRATYEAFVPADA	FUT7	256	Q11130
DPEVAALYFPKNGDP	LPIN1	406	Q14693
YTPELEAGNLAPIFP	MYCLP1	126	P12525
GDYPIPLSRPAAAYE	MIGA2	306	Q7L4E1
NIYPRTGPPSYAKDD	LAMA2	181	P24043
DPRLALEVYFGPCSP	FMO6P	461	O60774
PALDAVSAFKGPYAP	EGR4	296	Q05215
GDYQAAPEARFPVIG	EGR4	326	Q05215
PAVPANRLYPSGAYD	EGR4	356	Q05215
TFLYGPPDPAVRATD	IRF7	311	Q92985
CGSPPYAAPELFRDE	NIM1K	231	Q8IY84
SINIPRFYFPEGLPD	PPP2R3A	706	Q06190
VPFPSRLGDPAEYAH	HSD17B10	221	Q99714
SRALDPAGNESAYPP	LYPD3	121	O95274
VNSAFPRPAYDPSLN	PTPRR	81	Q15256
DLPKDPAGPFFQLRY	DCHS2	211	Q6V1P9
PRSYLVAGANPAAFP	PGR	401	P06401
PAGAYNLDPQRPVHF	ITGA9	26	Q13797
PPDAFYGPQELAAAA	GBX1	111	Q14549
YDPPPSRQAGGLSRF	CHRDL1	211	Q9BU40
AYGVRAPHPDQPEFT	COL14A1	1766	Q05707
GERYLFPNPASAFPV	GAB4	486	Q2WGN9
QPAPARGDFAYAAPA	DUX4L9	231	Q6RFH8
PFDPAVGSDPEFARY	GARRE1	836	O15063
AEVGAPAPLAYVPEF	UGT8	166	Q16880
DAPPLDLRFNPSGYL	FOXRED1	146	Q96CU9
RPVYELSPDPNNTGF	TMEM30B	231	Q3MIR4
RAADNDPTAPPYDSL	CDH4	851	P55283
QPFAASVPRDGASYP	AKNA	956	Q7Z591
ETAAVYRSPPEGFDP	CYP26C1	416	Q6V0L0
YRSPPEGFDPERFGA	CYP26C1	421	Q6V0L0
QPAPARGDFAYAAPA	DUX4L7	231	P0CJ90
AAFNPYLGPVSPSLV	MBNL1	131	Q9NR56
LGRYPEEDNEAFPLP	DENND4B	216	O75064
AAASEDARQPAKPPY	FOXD4L1	96	Q9NU39
PSRPADNYDNFVLPE	IST1	311	P53990
TDPEQRAQEPRYPGF	GK5	6	Q6ZS86
RDPEFAPPSDYFVGQ	CCDC174	386	Q6PII3
PRPGQATSHIFYEPD	ELP5	286	Q8TE02
DAPPNANLRYRFVGP	CELSR3	461	Q9NYQ7
QPAPARGDFAYAAPA	DUX4L5	231	P0CJ88
RQGAAFYAPGREPVP	HELZ2	1391	Q9BYK8
TGLPDDIPFRNPNTY	GTF2IRD1	841	Q9UHL9
NPGFPEPRALFYTAQ	GRK1	286	Q15835
PGLDCPRVRYPDFND	DNAH10	2061	Q8IVF4
RESYQQEAPGGPRAP	PIWIL3	16	Q7Z3Z3
RAQASYAGPPPTVAE	SCNN1B	566	P51168
GSPYLAALAPNLFPF	C3orf56	116	Q8N813
IDYSLAPEAPFPRAL	LIPE	681	Q05469
FLFSVPAGPPAQYSV	PKD1	686	P98161
ESPPDYSAAPRGRFG	SFTPC	11	P11686
AEINYLLGPDAPPEF	PCDH11Y	531	Q9BZA8
DESPLGAPYVRNTPQ	MAP3K14	181	Q99558
YLPLPEAAPAQGQAD	PCDHB8	671	Q9UN66
VDGFSQPYLPLPEAA	PCDHB6	661	Q9Y5E3
YPATAAGLKRPPAYE	NYAP1	551	Q6ZVC0
DPGAFYLDLQPSPFE	RUSC2	316	Q8N2Y8
VFLPQGFPDSVSPDY	RUSF1	76	Q96GQ5
FFTGRLDAPIISYPP	RSPH4A	461	Q5TD94
RLFQTAFPAPYGPSP	TAF6L	576	Q9Y6J9
RFQGEYGSDPEERPP	UTP25	391	Q68CQ4
GAPDVISPRYDPDSG	TRIM46	621	Q7Z4K8
QVPYDPALGSPSRLF	SP5	56	Q6BEB4
DYTRPDLPSGDGQPA	PTBP2	271	Q9UKA9
KPEAAPLLGDYQDPF	SYNJ2	1401	O15056
PPLFSPEEDAVFYNG	FER1L5	1621	A0AVI2
GDNPNSSDYPAPRAV	NBEA	2761	Q8NFP9
LEGFYRASSDPPEAP	EPHB6	351	O15197
ADPPGPENLFVNYLS	HID1	316	Q8IV36
DLGPPSYVPATAFLQ	SMG1	2591	Q96Q15
PDTLCFQIRGAAPPY	PREX1	716	Q8TCU6
LPDGPDAPADRQQYL	SNAP29	31	O95721
ENVPENSRPATGYPL	SH3BGRL	51	O75368
YRAPECDQPDNRPGF	SLC5A3	491	P53794
PPGLDEYNPFSDSRT	SCAMP1	31	O15126
QDVSFAYPNRPDRPV	TAP2	471	Q03519
SPVGDFYRLIPQPAF	SKIV2L	291	Q15477
DFAYPAATREPPSLQ	TEX45	46	Q8NA69
LVPYFVPNTPAARAD	SGSH	221	P51688
LYGQPVAAGDTPAPR	RRP12	696	Q5JTH9
SIPNGDFRPVCYEEP	SMAD9	256	O15198
IGAAEDDRPYLAPPA	SHANK1	891	Q9Y566
FQLPDAGAAPPAYEG	B3GNT9	56	Q6UX72
PTPTGPFDFARYLRA	B3GNT9	76	Q6UX72
IPPPDYGAASRAFPA	BAIAP2	466	Q9UQB8
LTLDIFAGPPNYPFS	AKR1C1	306	Q04828
LTLDIFAGPPNYPFS	AKR1C2	306	P52895
PRPNSAEESNGPIYA	CILP	881	O75339
PSGLSFEYPRDPEHR	CHRD	136	Q9H2X0
PSLDRYGQKPLPFDS	TEPP	236	Q6URK8
NSQLPESFRVPYDPG	PIK3CG	776	P48736
PVASPRTDPYAAGAQ	ZIC3	201	O60481
DRDAQFYRFPGPEPE	RAPGEF3	176	O95398
ASPPSFLQGLCRDPY	ZNF703	366	Q9H7S9
PDLDVQYRSGAAPQP	PLAUR	296	Q03405
QDFAYGSRPQEPVPT	ZFR2	66	Q9UPR6
FLRDPYVLPAASDFP	SNX24	136	Q9Y343
QPGVAYPAFLGPDEA	SPSB4	156	Q96A44
YPAFLGPDEAFALPD	SPSB4	161	Q96A44
FPSPHQPRYDTALAG	KBTBD13	241	C9JR72
APPQRPQDDYSVLFE	SGF29	251	Q96ES7
YSFVFSRDPNGLPPE	RBP4	151	P02753
DPSFQYPGNFARPLE	PFAS	366	O15067
PPFREFPSNLGYSEL	VPS18	256	Q9P253
APGSPRALNPQDYVA	SLC12A9	671	Q9BXP2
YDIASPNAGPLFRVP	TPP2	616	P29144
PPPICRAASLDGFYN	SEZ6	891	Q53EL9
EALRGPFSQFRYEPP	ZNF366	46	Q8N895
PFSQFRYEPPPGDLD	ZNF366	51	Q8N895
SSPNPFPEISRGEYL	ZNF8	186	P17098
AAVSAFLQPGAPRPY	TRAPPC8	466	Q9Y2L5
PSPQGEELHPSRFYE	PLEKHG7	166	Q6ZR37
GREHVNPEYFPPASA	TRANK1	961	O15050
YFRVGVDPDQDPPPN	SLC9A7	556	Q96T83
TQSPPSFYRAGDPIL	TCTN3	201	Q6NUS6
SSFPDPALYPLGSRQ	FLT1	436	P17948
DQFLGVPYAAPPLAE	TG	2226	P01266
NFAAPRREVAPPYQG	TNFRSF1A	306	P19438
AQGRRLPQPEYCPDS	MST1R	1301	Q04912
HGPEDSAPQYSRLFP	SULF2	226	Q8IWU5
DDDFEPYLSPQARPN	YTHDF2	31	Q9Y5A9
DAPRDPDPSQYQSLG	TSPYL5	31	Q86VY4
QPAPARGDFAYAAPA	DUX4L2	231	P0CJ85
NYPAAPASDPLREGS	KDM5C	1326	P41229
FYPVSEDPHRLAPEG	KMT2D	2906	O14686